Document Detail

Butyrate-rich colonic microenvironment is a relevant selection factor for metabolically adapted tumor cells.
MedLine Citation:
PMID:  20926374     Owner:  NLM     Status:  MEDLINE    
The short chain fatty acid (SCFA) butyrate is a product of colonic fermentation of dietary fibers. It is the main source of energy for normal colonocytes, but cannot be metabolized by most tumor cells. Butyrate also functions as a histone deacetylase (HDAC) inhibitor to control cell proliferation and apoptosis. In consequence, butyrate and its derived drugs are used in cancer therapy. Here we show that aggressive tumor cells that retain the capacity of metabolizing butyrate are positively selected in their microenvironment. In the mouse xenograft model, butyrate-preselected human colon cancer cells gave rise to subcutaneous tumors that grew faster and were more angiogenic than those derived from untreated cells. Similarly, butyrate-preselected cells demonstrated a significant increase in rates of homing to the lung after intravenous injection. Our data showed that butyrate regulates the expression of VEGF and its receptor KDR at the transcriptional level potentially through FoxM1, resulting in the generation of a functional VEGF:KDR autocrine growth loop. Cells selected by chronic exposure to butyrate express higher levels of MMP2, MMP9, α2 and α3 integrins, and lower levels of E-cadherin, a marker for epithelial to mesenchymal transition. The orthotopic model of colon cancer showed that cells preselected by butyrate are able to colonize the animals locally and at distant organs, whereas control cells can only generate a local tumor in the cecum. Together our data shows that a butyrate-rich microenvironment may select for tumor cells that are able to metabolize butyrate, which are also phenotypically more aggressive.
Jacinta Serpa; Francisco Caiado; Tânia Carvalho; Cheila Torre; Luís G Gonçalves; Cristina Casalou; Pedro Lamosa; Margarida Rodrigues; Zhenping Zhu; Eric W F Lam; Sérgio Dias
Related Documents :
3152764 - Tumour necrosis factor.
9744764 - Expression of group ii phospholipase a2 in paneth cells of an adenoma of the rectum. a ...
8927564 - Immunohistochemical pattern of bcl-2- and pthrp-positive cells in primary, in recurrent...
18538864 - Chemokine production and chemokine receptor expression by human glioma cells: role of c...
126564 - Immunoadjuvant activities of cell walls, their water-soluble fractions and peptidoglyca...
25309834 - Comparative analysis of the mitochondrial physiology of pancreatic β cells.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-10-06
Journal Detail:
Title:  The Journal of biological chemistry     Volume:  285     ISSN:  1083-351X     ISO Abbreviation:  J. Biol. Chem.     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-12-06     Completed Date:  2011-01-10     Revised Date:  2013-07-03    
Medline Journal Info:
Nlm Unique ID:  2985121R     Medline TA:  J Biol Chem     Country:  United States    
Other Details:
Languages:  eng     Pagination:  39211-23     Citation Subset:  IM    
Angiogenesis Group, Instituto Português de Oncologia de Francisco Gentil, Centro de Lisboa, EPE (CIPM/IPOLFG), Lisbon 1099-023, Portugal.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Butyrates / pharmacology*
Cell Line, Tumor
Colon / metabolism*
Fatty Acids / chemistry
Gene Expression Regulation, Neoplastic*
Histone Deacetylases / metabolism
Intercellular Signaling Peptides and Proteins / metabolism
Mice, Inbred BALB C
Mice, SCID
Neoplasm Metastasis
Neoplasm Transplantation
Neoplasms / metabolism*
Vascular Endothelial Growth Factor A / metabolism
Reg. No./Substance:
0/Butyrates; 0/Fatty Acids; 0/Intercellular Signaling Peptides and Proteins; 0/Vascular Endothelial Growth Factor A; EC Deacetylases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Noncanonical tandem SH2 enables interaction of elongation factor Spt6 with RNA polymerase II.
Next Document:  The sphingosine kinase 1 inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl)thiazole induces proteasom...